Efficacy and Safety of Intra-arterial Tenecteplase in Acute Ischemic Stroke Patients With Medium Vessel Occlusion Stroke (DATE-MeVO)
A phase 3 trial registered on ClinicalTrials.gov. The registry status is not yet recruiting. It plans to enroll 488 participants.
Also called NCT07469293
- Study
- In this atlas
Overview
- Design
- Interventional study; randomized; no masking; primary purpose treatment
- Phase
- Phase 3
- Enrolled
- 488 participants
- Sponsor
- Registry
-
NCT07469293
-
- Planned start
- (anticipated)
- Primary completion
- (anticipated)
- Completion
- (anticipated)
- Countries
- China
- Registry status
- Not yet recruiting
Technical summary
Registry record NCT07469293. Randomized; no masking; primary purpose treatment. Start 2026-03-25 (anticipated); primary completion 2028-12-31 (anticipated). Results not posted.
The registry's words
Labels as the registry gives them, not rewritten.
- Brief title
- Efficacy and Safety of Intra-arterial Tenecteplase in Acute Ischemic Stroke Patients With Medium Vessel Occlusion Stroke (DATE-MeVO)
- Condition
- Acute Ischemic Stroke
- Intervention (Procedure)
- Intra-arterial thrombolysis
- Intervention (Other)
- Standard medical treatment
- Lead sponsor
- Southwest Hospital, China
Record details
- Record id
cardio:ct-nct07469293- Content hash
c41275cfbd9625b81508a9a62da88ec2661e511ab83ff1012a8ac90c7f9d8ae4